Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -
Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, December 6, 2014
Inspiring: Owner of Bucci's restaurant in Centennial waits tables in her wheelchair, despite multiple sclerosis
Shifting the Paradigm in Multiple Sclerosis Treatment by Targeting New Pathways
CREDITS LEARN More of this event
Friday, December 5, 2014
Discussing multiple sclerosis (MS) symptoms is viewed positively by neurologists and patients, but remains a struggle, according to research presented at the joint ACTRIMS-ECTRIMS conference held September 10-13 in Boston.
Surveyors from Harris Poll, on behalf of Biogen Idec, developed a survey which encompassed neurologists from 5 countries (Germany, Italy, Spain, the United States, and the United Kingdom) and representatives from patient advocacy groups between March and April 2014. The survey was conducted in order to gain a deeper understanding of MS patients’ lives and to highlight communication between MS patients and their doctors.
About 83 percent of patients noted they felt comfortable talking with their neurologists about MS and reported their neurologist provided them with helpful information (81 percent). Nearly all neurologists surveyed (96 percent) felt they had an open dialogue with patients, and said patients can ask them anything they want. The majority of neurologists (90 percent) indicated they had a good understanding of their patients’ disease; however, the surveyors note a disconnect is still present surrounding certain MS symptoms. Almost 20 percent of patients who experience MS symptoms report being uncomfortable with their neurologist about the following: difficulty walking (19 percent), tremors (19 percent), and muscle spasms (18 percent).
However, only 2-3 percent of neurologists noted these same topics as uncomfortable for discussion with their patients. Neurologists across the board identified similar topics that were uncomfortable in discussion, and anticipate a higher level of discomfort than described by patients. These symptoms identified by neurologists as uncomfortable were: sexual difficulties (28 percent, with 87 percent perceiving this as uncomfortable for patients), bladder or bowel problems (28 percent, 54 percent), mood swings (26 percent, 37 percent), and cognitive or memory issues (21 percent, 37 percent).
- The report provides a snapshot of the global therapeutic landscape of Secondary Progressive Multiple Sclerosis (SPMS)
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Secondary Progressive Multiple Sclerosis (SPMS) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Secondary Progressive Multiple Sclerosis (SPMS) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Secondary Progressive Multiple Sclerosis (SPMS) pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products
Dear MS-Leaders Registrant,
Last Chance to Earn 0.50 Hours of Free CME or CNE Credit!
The University of Texas Southwestern Medical Center and Postgraduate Institute for Medicine, in cooperation with Medical Logix, LLC are pleased to offer this CME/CNE certified program:
Certification for this CME/CNE program will expire on December 9, 2014.
Acknowledgement of Commercial Support: Supported by independent educational grants from Genzyme, a Sanofi company and Novartis.
This activity is intended for healthcare professionals, specifically, neurologists, internists, family practice physicians, nurse practitioners, physician assistants, registered nurses and other providers involved in the care of patients with multiple sclerosis.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Texas Southwestern Medical Center and Medical Logix LLC. The University of Texas Southwestern Medical Center is accredited by the ACCME to provide continuing medical education for physicians.
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Credit Designation Statement:
The University of Texas Southwestern Medical Center designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(TM). Participants should claim only the credit commensurate with the extent of their participation in the activity.
This educational activities for 0.5 contact hours is provided for nurses by Postgraduate Institute for Medicine.
Format and Method of Participation:
There are no fees for participating and receiving CME or CNE credit for this activity. During the accreditation period, participants must read the learning objectives and faculty disclosures and review each internet-based activity. To take the post-test, please click on the post-test button below the slide window of the player. Complete the post-test and evaluation and attest to the amount of time spent in each activity. Upon receiving a score of 70% or above, print your CME or CNE certificate.
Please keep in mind that you will need to login with your email address and password to access this program. If you forgot your password, click on the 'Forgot Password' link in the top right corner of the site.
Thursday, December 4, 2014